News
Home | News
![SingaporeGroundbreakingGroupPhoto WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers](https://tides.wuxiapptec.com/wp-content/uploads/2024/05/SingaporeGroundbreakingGroupPhoto.jpg)
WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers
May 23, 2024Photo caption (from left to right): Ms. Cindy Koh, Executive Vice President, Singapore Economic Development Board; Dr. Minzhang Chen, Co-CEO, WuXi AppTec; Mr. Heng Swee Keat, Deputy Prime Minister; Dr. Ge Li,…
![1712611282014 A Successful PAI for a new Peptide Drug from Japan PMDA](https://tides.wuxiapptec.com/wp-content/uploads/2024/05/1712611282014.jpg)
A Successful PAI for a new Peptide Drug from Japan PMDA
April 9, 2024Our peptide manufacturing facility at Changzhou site has successfully passed the Pre-Approval Inspection by Japan Pharmaceuticals and Medical Devices Agency (PMDA) for an innovative peptide drug. The 3-day inspection, without any major…
![CDMO2024 2024 CDMO Leadership Awards](https://tides.wuxiapptec.com/wp-content/uploads/2024/03/CDMO2024.jpg)
2024 CDMO Leadership Awards
March 21, 2024Exciting moment! We’ve been honored with the 2024 CDMO Leadership Awards in all six core categories: Capabilities, Compatibility, Expertise, Quality, Reliability, and Service, again! Dr. Jinling Chen, our Senior Vice President and…
![WuXi_STA_Taixing_site](https://tides.wuxiapptec.com/wp-content/uploads/2024/01/Taixing_news.jpg)
WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site
January 8, 2024Expansion Boosts Solid-Phase Peptide Synthesis Total Reactor Volume to 32,000 Liters in Response to Surging Demand Shanghai, China – January 8, 2024 — WuXi AppTec, a global company that provides a broad…
![WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site](https://tides.wuxiapptec.com/wp-content/uploads/2023/08/WuXi-STA-Debuts-Its-First-High-Potency-Sterile-Injectable-Manufacturing-Line-at-Wuxi-City-Site.jpg)
WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site
July 17, 2023Shanghai, China, July 17, 2023 -- WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO), today launched its first high potency (HP), fully automated sterile injectable manufacturing line at the…
![WuXi STA Forms Strategic Partnership with Ark Biopharmaceutical for the Commercial Supply of Ziresovir WuXi STA Forms Strategic Partnership with Ark Biopharmaceutical for the Commercial Supply of Ziresovir](https://tides.wuxiapptec.com/wp-content/uploads/2023/09/WuXi-STA-Forms-Strategic-Partnership-with-Ark-Biopharmaceutical-for-the-Commercial-Supply-of-Ziresovir.jpg)
WuXi STA Forms Strategic Partnership with Ark Biopharmaceutical for the Commercial Supply of Ziresovir
May 23, 2023SHANGHAI, CHINA, May 23, 2023 - WuXi STA, a subsidiary of WuXi AppTec, and Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced a strategic partnership for the commercial supply of ziresovir, a novel…